Advertisement

Topics

Latest "Havel Incorporated" News Stories

16:23 EDT 25th April 2018 | BioPortfolio

Here are the most relevant search results for "Havel Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Havel Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Havel Incorporated for you to read. Along with our medical data and news we also list Havel Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Havel Incorporated Companies for you to search.

Showing "Havel Incorporated" News Articles 1–25 of 53

Relevant

Veteran Zeman wins last big battle in Czech presidential vote

By Jan Lopatka PRAGUE (Reuters) - Milos Zeman, the longest-standing figure in Czech post-communist politics, won a final major battle on Saturday, showing off his strong political instincts to secure a second presidential term. Zeman, 73, bet on a populist anti-immigration stance and sniping at intellectual Prague elites to mobilize his base and gain a narrow win over Jiri Drahos, a mainstream p...


Probably Relevant

TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

REGULATED INFORMATIONPRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 16, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") announced today that it received transparency notifications pursuant to Article 14 of the Belgian Law of May 2, 2007 regarding the publication of maj...

Robert A. Essner, former Chairman and Chief Executive of Wyeth, named Executive Chairman of Elucida Oncology, Inc.

NEW YORK, NY--(Marketwired - April 25, 2018) - ELUCIDA ONCOLOGY, INC®, a biotechnology company focused on developing and commercializing a first-in-class, ultra-small nanoparticle platform technology for the diagnosis and treatment of cancer, announced today that it has appointed Robert A. Essner as its Executive Chairman. Mr. Essner was Chairman and Chief Executive Officer for Wyeth, acquired by...


Global Carbon refractories Market Research Report Forecast 2017 to 2021 [Report Updated: 20112017] Prices from USD $2800

The Global Carbon refractories Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Carbon refractories industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description of the value chain and its distributor analysis. Thi...

Possibly Relevant

Novartis tender offer for Advanced Accelerator Applications commences

Novartis International AG / Novartis tender offer for Advanced Accelerator Applications commences . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Basel, December 7, 2017 -Novartis AG (NYSE: NVS) ("Novartis") today announced that its direct and indirect subsidiary, Novartis Groupe France S...

NOTICE IN RELATION TO WAIVER OF LOCK-UP RESTRICTION

REGULATED INFORMATION GHENT, Belgium, 27 December 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC and Jefferies LLC, the lead book-running managers in the Company's recent public sale of 13,144,500 ordinary shares in the form of American Depositary Shares, including 1,714...

Intellegens secures first commercial contract for Alchemite™ technology

Cambridge, UK - 5 February 2018 - The potential of Intellegens’ Alchemite™ artificial intelligence (AI) technology has been demonstrated with the recent announcement of a commercial collaboration between the Cambridge-based company and e-Therapeutics; the Oxford-based pioneer of Network-Driven Drug Discovery (NDD). In its first commercial application, Alchemite™ will enable ...

Teleflex Completes Previously Announced CEO Transition

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, announced today that it has completed its previously announced senior leadership transition. Effective January 1, 2018, Liam Kelly, who previously served as Teleflex’s President and Chief Operating Officer, assumed the position of Presiden...

Novartis tender offer for AveXis commences

Novartis International AG / Novartis tender offer for AveXis commences . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Basel, April 17, 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced that its indirect wholly-owned subsidiary, Novartis AM Merger Corporation, a Delaware corporation...

SpeeDx receives FDA clearance for Mycoplasma genitalium product

SYDNEY, Australia, April 19, 2018 (GLOBE NEWSWIRE) -- SpeeDx's ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale in the United States through the company's recently incorporated US entity, SpeeDx Inc. The announcement coincides with the FDA registration of the Australian parent company - SpeeDx Pty Ltd - as a Medi...

FIT Biotech Oy: Resolutions of Extraordinary General Meeting December 14, 2017

FIT Biotech OyCompany release December 14, 2017 at 12 am. Resolutions of Extraordinary General Meeting December 14, 2017                The EGM of FIT Biotech ("FIT Biotech", "company") has made the following resolutions today. Amendment to the Articles of Association    The Extraordinary General Meeting resolved to amend section 4 of ...

Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction

Molecular Health GmbH / Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Cambridge, MA, USA - November 16, 2017 -  Molecular Health, Inc (MH), a company marketing computational biomedicine...

Teleflex Incorporated Announces Public Offering of $500 Million of Senior Notes

Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the registered public offering, subject to market and other conditions, of $500.0 million aggregate principal amount of senior notes due 2027 (the “Notes”). The interest rate and other terms of the Notes will be determined at pricing. The Notes will be guaranteed by each of Tel...

Avacta and Oncosec to Collaborate on Innovative Gene Delivery of Therapeutic Affimers

Wetherby and Cambridge, UK, 22 January 2018: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, and OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, are pleased to announce they have entered into a research collaboration to combine Avacta’s Affimer protein platform with Onc...

Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering

Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its offering of $500.0 million aggregate principal amount of 4.625% senior notes due 2027 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on November 20, 2017, subject to customary closing conditions. The Notes will be guar...

Relevium Launches New Bioganix Brand Architecture

MONTREAL, QUEBEC -- (Marketwired) -- 03/29/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce it has completed the re-positioning of its Bioganix brand. The new re-positioning enhances Bioganix around the key branding points of Credibility, Quality and Trust. The Company will be rolling out its new brand and new ...

Relevium Targets 83 Million Unique Monthly Visitors and 26 Countries Through European Expansion of Bioganix(R)

MONTREAL, QUEBEC -- (Marketwired) -- 04/05/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it has started the process of establishing European presence for the new Bioganix® brand in partnership with several online partners, including Amazon. Management will be doing an initial launch of eight best selli...

MedPharm launches new automated performance testing services, MedStat-HTTM and MedFlux-HT® for de-risking and accelerating the development of topical medicines

MedPharm, the world leader in formulation and in vitro performance testing of topical medicines, has launched two automated testing services, MedStat-HT and MedFlux-HT® to de-risk client’s development programs and shorten development timelines. Both pieces of equipment incorporated design features which provide significant improvements over commercially available systems. MedFlux-HT...

Relevium Clarifies Operational Update

MONTREAL, QUEBEC -- (Marketwired) -- 02/23/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to provide further clarifications on its press release from earlier today. The Company has received several requests from active shareholders to clarify ambiguity in the language of the operational press release from earlier in the...

Relevium Commences Trading on OTCQB

MONTREAL, QUEBEC -- (Marketwired) -- 02/20/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it has commenced trading on the OTCQB under the symbol RLLVF Aurelio Useche, President and CEO of Relevium stated: "We have been focused on an industry and technologies that, from our analytics resonate very well i...

Congenica Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27022018] Prices from USD $250

Summary   Congenica Ltd Congenica is a biotechnology company that offers clinical decision support software and services . The company's technology SAPIENTIA, is used to personalize patient care through accurate diagnoses and analysis of genomic data. It offers services such as variant interpretation and clinical reporting. The company's clinical reporting allows share access of...

Relevium Improves Financial Position and Provides Updates on Warrants Exercises and Share for Services Agreement

MONTREAL, QUEBEC -- (Marketwired) -- 02/05/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to report improvements on its financial position, provide an update on warrants exercised to date and on shares issued to its corporate secretary on a share for services agreement. Improved Financial Position and Warrants Exercises to-date The c...

Milestone Scientific's CompuFlo(R) Epidural System, Wand(R) STA Dental System and Cosmetic Instrument Featured in Television Broadcasts and in Premier Online News Journal

LIVINGSTON, NJ--(Marketwired - November 28, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Wand® STA Dental and CompuFlo® Epidural systems were featured in separate television news broadcasts in Pittsburgh and South Florida, respectively....

Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink

CALGARY, Alberta, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has closed its previously announced private placement of 60,416,667 equity units to Shenzhen Hepalink Pharmaceutical Co. Ltd. ("Hepalink") at a price of $1.44 per unit for gross proceeds of $87 million. Each unit was comprised ...

Relevium Announces All-Time Record High of Units Sales for Bioganix(R) in March

MONTREAL, QUEBEC -- (Marketwired) -- 04/03/18 -- Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to report an all-time record high in unit sales for the month of March 2018. The reported record high of 16,549 units, which was achieved in a seasonally low period, reflects increased online demand for the Bioganix® established p...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks